Works matching IS 03065251 AND DT 1997 AND VI 43 AND IP 3
1
- British Journal of Clinical Pharmacology, 1997, v. 43, n. 3, p. 223, doi. 10.1046/j.1365-2125.1997.00551.x
- Penston, J. G.;
- L McColl, K. E.
- Article
2
- British Journal of Clinical Pharmacology, 1997, v. 43, n. 3, p. 219, doi. 10.1111/j.1365-2125.1997.00562.x
- Cleophas, T. J. M.;
- Meulen, J. v.d.;
- Kalmansohn, R. B.
- Article
3
- British Journal of Clinical Pharmacology, 1997, v. 43, n. 3, p. 283, doi. 10.1046/j.1365-2125.1997.00544.x
- Article
4
- British Journal of Clinical Pharmacology, 1997, v. 43, n. 3, p. 327, doi. 10.1111/j.1365-2125.1997.00555.x
- Hood, Stuart;
- Hillis, Stewart
- Article
5
- British Journal of Clinical Pharmacology, 1997, v. 43, n. 3, p. 259, doi. 10.1111/j.1365-2125.1997.00566.x
- Benowitz, N.L.;
- Zevin, S.;
- Jacob, P.
- Article
6
- British Journal of Clinical Pharmacology, 1997, v. 43, n. 3, p. 319, doi. 10.1046/j.1365-2125.1997.00548.x
- Lefebvre, Romain A.;
- Van Peer, Achiel;
- Woestenborghs, Robert
- Article
7
- British Journal of Clinical Pharmacology, 1997, v. 43, n. 3, p. 301, doi. 10.1046/j.1365-2125.1997.00559.x
- Ferro, A.;
- Hall, J. A.;
- Dickerson, J. E. C.;
- Brown, M. J.
- Article
8
- British Journal of Clinical Pharmacology, 1997, v. 43, n. 3, p. 291, doi. 10.1046/j.1365-2125.1997.00554.x
- Eagles, C. J.;
- Kendall, M. J.
- Article
9
- British Journal of Clinical Pharmacology, 1997, v. 43, n. 3, p. 273, doi. 10.1046/j.1365-2125.1997.00547.x
- Dixon*, Ruth;
- Gillotin, Catherine;
- Gibbens, Michael;
- Posner, John;
- Peck, Richard W.
- Article
10
- British Journal of Clinical Pharmacology, 1997, v. 43, n. 3, p. 329, doi. 10.1046/j.1365-2125.1997.00545.x
- McDowell, G.;
- Coutie, W.;
- Shaw, C.;
- Buchanan, K. D.;
- Struthers, A. D.;
- Nicholls, D. P.
- Article
11
- British Journal of Clinical Pharmacology, 1997, v. 43, n. 3, p. 309, doi. 10.1046/j.1365-2125.1997.00553.x
- Kiely, David G.;
- Cargill, Robert I.;
- Lipworth, Brian J.
- Article
12
- British Journal of Clinical Pharmacology, 1997, v. 43, n. 3, p. 269, doi. 10.1046/j.1365-2125.1997.00506.x
- Läer, S.;
- Neumann, J.;
- Scholz, H.
- Article
13
- British Journal of Clinical Pharmacology, 1997, v. 43, n. 3, p. 253, doi. 10.1111/j.1365-2125.1997.00546.x
- Rasmussen, Birgitte Buur;
- Brøsen, Kim
- Article
14
- British Journal of Clinical Pharmacology, 1997, v. 43, n. 3, p. 219, doi. 10.1046/j.1365-2125.1997.00552.x
- Cleophas, T. J. M.;
- Meulen, J. v.d.;
- Kalmansohn, R. B.
- Article
15
- British Journal of Clinical Pharmacology, 1997, v. 43, n. 3, p. 336, doi. 10.1046/j.1365-2125.1997.00564.x
- Hindle, M.;
- Peers, E. M.;
- Parry-Billings, M.;
- Chrystyn, H.
- Article
16
- British Journal of Clinical Pharmacology, 1997, v. 43, n. 3, p. 333, doi. 10.1046/j.1365-2125.1997.00563.x
- Article
17
- British Journal of Clinical Pharmacology, 1997, v. 43, n. 3, p. 315, doi. 10.1046/j.1365-2125.1997.00539.x
- Spina, E.;
- Avenoso, A.;
- Campo, G. M.;
- Scordo, M. G.;
- Caputi, A. P.;
- Perucca, E.
- Article
18
- British Journal of Clinical Pharmacology, 1997, v. 43, n. 3, p. 245, doi. 10.1046/j.1365-2125.1997.00556.x
- Zhang, H.;
- Coville, P. F.;
- Walker, R. J.;
- Miners, J. O.;
- Birkett, D. J.;
- Wanwimolruk, S.
- Article